UCSF

ZINC01530688

Substance Information

In ZINC since Heavy atoms Benign functionality
October 6th, 2004 21 No

Other Names:

1-(3-Methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene hydrochloride; 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, hydrochloride; 9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-, hydrochloride; 9-(gamma-Methylaminopropyl)-9,10-dihydro-9,10

10262-69-8

10262-69-8; C07107; Maprotiline

10262-69-8; D02566; Maprotiline (USAN)

10347-81-6 (hydrochloride)

10347-81-6; D00818; Ludiomil (TN); Maprotiline hydrochloride (JP16/USP)

10347-81-6; Maprotiline hydrochloride; Prestwick_749

276-Ba

3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)-N-methylpropan-1-amine

3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine

3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine

58902-67-3 (mesylate)

9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-

9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-

AB00514665

AC-12507

AC1L1H7N

Ba-34,276

BA-34276

BA-34276 [As Hydrochloride]

BPBio1_000453

BRD-K03319035-003-02-7

BRD-K25433859-003-11-4

BRN 2385493

BSPBio_000411

BSPBio_001945

C07107

CAS-10347-81-6

CHEMBL21731

CID4011

CPD000148117; Maprotiline hydrochloride; SAM001246989

CPD000148117; Maprotilline HCl; 10347-81-6

CPD000148117; Maprotilline HCl; SAM001246989

D02566

DAP001150

DB00934

Deprilept

Deprilept, Ludiomil, Psymion

Dibencycladine

DivK1c_000891

EINECS 233-599-4

FDA

HMS2089K11

IDI1_000891

INN

JAN

JAN)

KBio1_000891

KBio2_001367

KBio2_003935

KBio2_006503

KBio3_001445

KBioGR_000469

KBioSS_001367

L001173

LS-66338

LUDIOLMIL

Ludiomil

Ludiomil Hydrochloride

Maprotilin

Maprotilina

Maprotilina [INN-Spanish]

Maprotilina [INN-Spanish];Maprotilinum [INN-Latin];Maprotylina [Polish]

Maprotiline

Maprotiline (BAN

Maprotiline (USAN)

Maprotiline Hcl

Maprotiline [USAN:BAN:INN]

Maprotiline, Ludiomil Hydrochloride

Maprotilinum

Maprotilinum [INN-Latin]

Maprotylina

Maprotylina [Polish]

MFCD00079464

MFCD00661057

MLS001201766

MolPort-002-507-847

MolPort-002-671-472

N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine

N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine

NCGC00015708-01

NCGC00015708-10

NCGC00016691-01

NCGC00018217-01

NCGC00024886-01

NCGC00024886-02

NCGC00024886-03

nchembio747-comp22

NINDS_000891

Prestwick0_000346

Prestwick1_000346

Prestwick2_000346

Prestwick3_000346

Psymion

SMP1_000169

SMR000641863

SPBio_000218

SPBio_002332

Spectrum2_000139

Spectrum3_000483

Spectrum4_000035

Spectrum5_000918

Spectrum_000887

STK711156

STOCK6S-18648

TBB066626

Tocris-0935

UNII-2U1W68TROF

USAN); Maprotiline HCl (FDA

USAN); Maprotiline Hydrochloride (JAN

USP

USP)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.01 10.79 -44.88 2 1 1 17 278.419 4

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.50e-04 g/l DrugBank-approved
Therapy antidepressant SMDC MicroSource
PUBCHEM_PATENT_ID EP0046136A2; EP0107134A1; EP0164311A2; EP0164311B1; EP0174342A1; EP0190969A2; EP0190969B1; EP0200213A2; EP0200213B1; EP0208617A1; EP0238765A2; EP0242589A2; EP0248548A2; EP0248548B1; EP0251459A2; EP0251459B1; EP0280290B1; EP0293351A2; EP0293351B1; EP029371 IBM Patent Data
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100747; 1 hydrogen chloride NIH Clinical Collection via PubChem
Target Reuptake inhibitor Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100747; SALT: 1 hydrogen chloride NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
DRD1-1-E Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 402 0.43 Binding ≤ 10μM
DRD3-1-E Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 504 0.42 Binding ≤ 10μM
DRD5-1-E Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 429 0.42 Binding ≤ 10μM
HRH1-2-E Histamine H1 Receptor (cluster #2 Of 2), Eukaryotic Eukaryotes 2 0.58 Binding ≤ 10μM
SC6A2-1-E Norepinephrine Transporter (cluster #1 Of 2), Eukaryotic Eukaryotes 12 0.53 Binding ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 5012 0.35 Functional ≤ 10μM
DRD2-2-E Dopamine D2 Receptor (cluster #2 Of 24), Eukaryotic Eukaryotes 665 0.41 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 402 0.43 Binding ≤ 1μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 665 0.41 Binding ≤ 1μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 504 0.42 Binding ≤ 1μM
DRD5_HUMAN P21918 Dopamine D5 Receptor, Human 429 0.42 Binding ≤ 1μM
HRH1_HUMAN P35367 Histamine H1 Receptor, Human 1.67 0.59 Binding ≤ 1μM
SC6A2_HUMAN P23975 Norepinephrine Transporter, Human 12 0.53 Binding ≤ 1μM
DRD1_HUMAN P21728 Dopamine D1 Receptor, Human 402 0.43 Binding ≤ 10μM
DRD2_HUMAN P14416 Dopamine D2 Receptor, Human 665 0.41 Binding ≤ 10μM
DRD3_HUMAN P35462 Dopamine D3 Receptor, Human 504 0.42 Binding ≤ 10μM
DRD5_HUMAN P21918 Dopamine D5 Receptor, Human 429 0.42 Binding ≤ 10μM
HRH1_HUMAN P35367 Histamine H1 Receptor, Human 1.67 0.59 Binding ≤ 10μM
SC6A2_HUMAN P23975 Norepinephrine Transporter, Human 12 0.53 Binding ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 10000 0.33 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Dopamine receptors
G alpha (i) signalling events
G alpha (q) signalling events
G alpha (s) signalling events
Histamine receptors
Na+/Cl- dependent neurotransmitter transporters

Analogs ( Draw Identity 99% 90% 80% 70% )